Trial Outcomes & Findings for Heart at Home- a Self-care Study (NCT NCT01759368)

NCT ID: NCT01759368

Last Updated: 2014-09-17

Results Overview

Number of heart failure related hospital days

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

94 participants

Primary outcome timeframe

From baseline until the end of the study at six months

Results posted on

2014-09-17

Participant Flow

Participant milestones

Participant milestones
Measure
Telemonitoring Assisted Self-care
Telemonitoring group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions. The measurements taken at home to be uploaded were: diastolic and systolic blood pressure, pulse, body weight and an assessment of symptoms. The symptom assessment concerned the patient's feelings of dizziness, dyspnea, palpitation, weakness and, oedema. Patients were also asked to evaluate their overall condition- whether their condition had deteriorated, improved or remained unchanged. The patients were advised to carry out and report the measurements together with the self-assessment once a week. The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit. In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
Control Group
Control group received multidisciplinary care that was standard.
Overall Study
STARTED
47
47
Overall Study
COMPLETED
46
47
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Telemonitoring Assisted Self-care
Telemonitoring group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions. The measurements taken at home to be uploaded were: diastolic and systolic blood pressure, pulse, body weight and an assessment of symptoms. The symptom assessment concerned the patient's feelings of dizziness, dyspnea, palpitation, weakness and, oedema. Patients were also asked to evaluate their overall condition- whether their condition had deteriorated, improved or remained unchanged. The patients were advised to carry out and report the measurements together with the self-assessment once a week. The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit. In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
Control Group
Control group received multidisciplinary care that was standard.
Overall Study
Lost to Follow-up
1
0

Baseline Characteristics

Heart at Home- a Self-care Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Telemonitoring-assisted Self-care
n=47 Participants
Telemonitoring group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions. The measurements taken at home to be uploaded were: diastolic and systolic blood pressure, pulse, body weight and an assessment of symptoms. The symptom assessment concerned the patient's feelings of dizziness, dyspnea, palpitation, weakness and, oedema. Patients were also asked to evaluate their overall condition- whether their condition had deteriorated, improved or remained unchanged. The patients were advised to carry out and report the measurements together with the self-assessment once a week. The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit. In case a patient did not mak
Control Group
n=47 Participants
Control group received usual care that includes multidisciplinary care approach in which patients receive guidance and support for self-care. In the care of HF patients, the cardiac team plays a central role in monitoring and interpreting patient symptoms, optimizing medication and providing education. The cardiac team consists of two physicians, one specialized heart failure nurse and a physiotherapist who helps after a hospitalization period. As part of the care process, patients capable of carrying out self-care are identified and they are encouraged to regularly measure their blood pressure, heart rate and weight at home. So far, the information exchange between heart failure patients and care personnel has taken place during patients' visits to the clinic and by telephone. Systematic collection and exploitation of the self-measurement data has been difficult, since it depends on the patient's own activity.
Total
n=94 Participants
Total of all reporting groups
Age, Continuous
57.9 years
STANDARD_DEVIATION 11.9 • n=93 Participants
58.3 years
STANDARD_DEVIATION 11.6 • n=4 Participants
58.0 years
STANDARD_DEVIATION 11.7 • n=27 Participants
Sex: Female, Male
Female
8 Participants
n=93 Participants
8 Participants
n=4 Participants
16 Participants
n=27 Participants
Sex: Female, Male
Male
39 Participants
n=93 Participants
39 Participants
n=4 Participants
78 Participants
n=27 Participants
left ventricular ejection fraction
27.3 percentage
STANDARD_DEVIATION 4.9 • n=93 Participants
28.6 percentage
STANDARD_DEVIATION 5.0 • n=4 Participants
28.0 percentage
STANDARD_DEVIATION 5.0 • n=27 Participants
NYHA ( Functional Classification of the New York Heart Association)
'Slight limitations in physical activity class II'
19 participants
n=93 Participants
17 participants
n=4 Participants
36 participants
n=27 Participants
NYHA ( Functional Classification of the New York Heart Association)
'Marked limitation in physical activity class III
27 participants
n=93 Participants
28 participants
n=4 Participants
55 participants
n=27 Participants
NYHA ( Functional Classification of the New York Heart Association)
'Severe limitations in physical activity class IV
1 participants
n=93 Participants
2 participants
n=4 Participants
3 participants
n=27 Participants
Body mass index
28.4 kg/m2
STANDARD_DEVIATION 6.0 • n=93 Participants
27.9 kg/m2
STANDARD_DEVIATION 4.0 • n=4 Participants
28.2 kg/m2
STANDARD_DEVIATION 5.4 • n=27 Participants
Smoking
Smoker
35 participants
n=93 Participants
42 participants
n=4 Participants
77 participants
n=27 Participants
Smoking
Non-smoker
12 participants
n=93 Participants
5 participants
n=4 Participants
17 participants
n=27 Participants
Systolic blood pressure
112 mmHg
STANDARD_DEVIATION 13 • n=93 Participants
116 mmHg
STANDARD_DEVIATION 16 • n=4 Participants
114 mmHg
STANDARD_DEVIATION 15 • n=27 Participants
Diastolic blood pressure
71 mmHg
STANDARD_DEVIATION 10 • n=93 Participants
72 mmHg
STANDARD_DEVIATION 10 • n=4 Participants
72 mmHg
STANDARD_DEVIATION 10 • n=27 Participants
NT-proBNP
2347 ng/l
n=93 Participants
1338 ng/l
n=4 Participants
1700 ng/l
n=27 Participants

PRIMARY outcome

Timeframe: From baseline until the end of the study at six months

Number of heart failure related hospital days

Outcome measures

Outcome measures
Measure
Telemonitoring Assisted Self-care
n=46 Participants
Telemonitoring assisted self-care group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions. A pre-installed software application in the mobile phone supported uploading of measurements and self-assessment of symptoms. The patients were advised to carry out and report the measurements together with the self-assessment once a week. Telemonitoring assisted self-care: The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit. In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
Control Group
n=47 Participants
Control group received usual care
Number of HF-related Hospital Days
0.7 number of days
Standard Deviation 2.4
1.4 number of days
Standard Deviation 3.5

SECONDARY outcome

Timeframe: From baseline until the end of the study at six months

Death from any cause

Outcome measures

Outcome measures
Measure
Telemonitoring Assisted Self-care
n=46 Participants
Telemonitoring assisted self-care group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions. A pre-installed software application in the mobile phone supported uploading of measurements and self-assessment of symptoms. The patients were advised to carry out and report the measurements together with the self-assessment once a week. Telemonitoring assisted self-care: The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit. In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
Control Group
n=47 Participants
Control group received usual care
Death
0 participants
0 participants

SECONDARY outcome

Timeframe: From baseline until the end of the study at six months

Heart transplant operation or listing for transplant operation

Outcome measures

Outcome measures
Measure
Telemonitoring Assisted Self-care
n=46 Participants
Telemonitoring assisted self-care group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions. A pre-installed software application in the mobile phone supported uploading of measurements and self-assessment of symptoms. The patients were advised to carry out and report the measurements together with the self-assessment once a week. Telemonitoring assisted self-care: The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit. In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
Control Group
n=47 Participants
Control group received usual care
Heart Transplant
0 participants
0 participants

SECONDARY outcome

Timeframe: From baseline until the end of the study at six months

Change in plasma concentration of brain natriuretic peptide propeptide from baseline to the end of the study.

Outcome measures

Outcome measures
Measure
Telemonitoring Assisted Self-care
n=46 Participants
Telemonitoring assisted self-care group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions. A pre-installed software application in the mobile phone supported uploading of measurements and self-assessment of symptoms. The patients were advised to carry out and report the measurements together with the self-assessment once a week. Telemonitoring assisted self-care: The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit. In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
Control Group
n=47 Participants
Control group received usual care
P-proBNP
-198 ng/l
Interval -1921.0 to 170.0
-50 ng/l
Interval -831.0 to 260.0

SECONDARY outcome

Timeframe: From baseline until the end of the study at six months

Change in self-care behaviour measured by the European Heart Failure Self-Care Behaviour Scale (EHFSBS). EHFSBS is a 12-item self-administered questionnaire specifically designed and tested for heart failure patients including statements on self-care behaviour essential in the care of HF. The statements are scored from one to five. The lower the score, the better the performance in self-care. The summary score is analysed.

Outcome measures

Outcome measures
Measure
Telemonitoring Assisted Self-care
n=46 Participants
Telemonitoring assisted self-care group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions. A pre-installed software application in the mobile phone supported uploading of measurements and self-assessment of symptoms. The patients were advised to carry out and report the measurements together with the self-assessment once a week. Telemonitoring assisted self-care: The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit. In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
Control Group
n=47 Participants
Control group received usual care
EHFSBS (European Heart Failure Self-Care Behaviour Scale ) Scores
-5.0 Scores on a scale
Interval -7.3 to -3.0
-3.8 Scores on a scale
Interval -5.4 to -2.1

SECONDARY outcome

Timeframe: From baseline until the end of the study at six months

Change in left ventricular ejection fraction from baseline until the end of the study

Outcome measures

Outcome measures
Measure
Telemonitoring Assisted Self-care
n=46 Participants
Telemonitoring assisted self-care group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions. A pre-installed software application in the mobile phone supported uploading of measurements and self-assessment of symptoms. The patients were advised to carry out and report the measurements together with the self-assessment once a week. Telemonitoring assisted self-care: The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit. In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
Control Group
n=47 Participants
Control group received usual care
Left Ventricular Ejection Fraction
5.0 percentage unit
Interval 1.8 to 8.1
4.2 percentage unit
Interval 1.8 to 6.5

SECONDARY outcome

Timeframe: From baseline until the end of the study at six months

Number of visits to nurse's reception

Outcome measures

Outcome measures
Measure
Telemonitoring Assisted Self-care
n=46 Participants
Telemonitoring assisted self-care group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions. A pre-installed software application in the mobile phone supported uploading of measurements and self-assessment of symptoms. The patients were advised to carry out and report the measurements together with the self-assessment once a week. Telemonitoring assisted self-care: The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit. In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
Control Group
n=47 Participants
Control group received usual care
Utilization of Health Care Resources
4.5 number of visits
Standard Deviation 2.2
2.7 number of visits
Standard Deviation 1.0

OTHER_PRE_SPECIFIED outcome

Timeframe: From baseline to the end of the study at six months

Change in plasma concentrations of creatinine, natrium, and potassium

Outcome measures

Outcome data not reported

Adverse Events

Telemonitoring Assisted Self-care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Anna-Leena Orsama

VTT Technical Research Centre of Finland

Phone: +358408485966

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place